Joint statement: NICE and SMC/HIS collaboration

25 November 2022 - NICE and SMC/HIS collaboration on the health technology appraisal of tixagevimab–cilgavimab (Evusheld) for preventing COVID-19. ...

Read more →

NICE partners with international health technology assessment bodies to boost collaboration on shared opportunities and challenges

12 October 2022 - Six health technology assessment bodies from three continents are to collaborate on a range of topics that ...

Read more →

EMA publishes minutes of bilateral EMA – EUnetHTA meeting (June 2022)

11 October 2022 - The chairs welcome participants to the first bilateral under the new Work Plan between EUnetHTA 21 ...

Read more →

CADTH partners with international health technology assessment bodies to boost collaboration on shared challenges

6 September 2022 - Six health technology assessment bodies from three continents will join forces to collaborate on a range of ...

Read more →

NASWSI and Project Orbis - are they essentially the same?

7 September 2022 - We compare and contrast the two initiatives to bring new medicines to the market faster. ...

Read more →

International work-sharing - first medicines approved by all five Access Consortium regulators

2 September 2022 - The TGA has approved two new medicines as part of the Access New Active-Substance Work-Sharing Initiative. ...

Read more →

Collaboration arrangement between the Department of Health and Aged Care and Health Technology Assessment bodies in the United Kingdom and Canada

5 September 2022 - The Department of Health and Aged Care has signed an international collaboration arrangement with five like minded ...

Read more →

Global regulators call for international collaboration to integrate real-world evidence into regulatory decision-making

20 July 2022 - EMA has endorsed a joint statement calling for international collaboration to enable the generation and use ...

Read more →

US seeks pharmaceutical deal with Switzerland to fast-track FDA approvals

27 June 2022 - The Biden administration wants to reach a narrow sectoral trade agreement with the Swiss pharmaceutical industry, ...

Read more →

Global regulators work towards strengthening collaboration on observational research beyond COVID-19 pandemic

20 June 2022 - Lessons learned from international collaboration on observational research during the pandemic were highlighted during the latest global ...

Read more →

EU HTA regulation: international preparatory meeting in Cologne

17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...

Read more →

Core network partners announced for CADTH’s post-market drug evaluation network

10 June 2022 - CADTH is pleased to announce the four successful core network partners of its inaugural post-market drug ...

Read more →

FDA, EMA officials discuss impediments to cell and gene therapies

17 May 2022 - The US FDA's top biologics regulator said the use of a “playbook” or platform approach ...

Read more →

MHRA approves faricimab through international work-sharing initiative

17 May 2022 - It is the first treatment approved by the UK regulator that has been made possible through the ...

Read more →

European collaboration on health technology assessment: looking backward and forward

19 April 2022 - The establishment of health technology assessment has been an important topic in Europe for many years. ...

Read more →